EDNRB isoform 3 confers Temozolomide resistance in A375 melanoma cells by modulating membrane potential, reactive oxygen species and mitochondrial Ca2+

EDNRB isoform 3 confers Temozolomide resistance in A375 melanoma cells by modulating membrane potential, reactive oxygen species and mitochondrial Ca2+

Yun Shan Chen,*,1 Fen Liu,*,1 Yi Hong Luo,1 Yue Fan,1 Fang Gui Xu,1 Pin Li,1 Bei Zhou,1 Xiu Yu Pan,1 Chi Chiu Wang,2–4 Long Cui1,41Department of Obstetrics and Gynaecology, Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, Guangzhou 510623, Guangdong, P...

Full description

Bibliographic Details
Main Authors: Chen YS, Liu F, Luo YH, Fan Y, Xu FG, Li P, Zhou B, Pan XY, Wang CC, Cui L
Format: Article
Language:English
Published: Dove Medical Press 2019-08-01
Series:Cancer Management and Research
Subjects:
melanoma
temozolomide
mitochondrial targeting sequence
apoptosis
reactive oxygen species
Online Access:https://www.dovepress.com/ednrb-isoform-3-confers-temozolomide-resistance-in-a375-melanoma-cells-peer-reviewed-article-CMAR

Internet

https://www.dovepress.com/ednrb-isoform-3-confers-temozolomide-resistance-in-a375-melanoma-cells-peer-reviewed-article-CMAR

Similar Items